Scarica l'app Stockscreener
4.41
2.32%
0.10
Dopo l'orario di chiusura:
4.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FHTX Giù?
Forum
Previsione
Precedente Chiudi:
$4.31
Aprire:
$4.36
Volume 24 ore:
152.10K
Relative Volume:
0.98
Capitalizzazione di mercato:
$249.30M
Reddito:
$34.16M
Utile/perdita netta:
$-98.43M
Rapporto P/E:
-1.8846
EPS:
-2.34
Flusso di cassa netto:
$-119.33M
1 W Prestazione:
+8.35%
1M Prestazione:
-9.82%
6M Prestazione:
+5.00%
1 anno Prestazione:
-42.13%
Intervallo 1D:
$4.15
$4.61
Intervallo di 1 settimana:
$3.94
$4.69
Portata 52W:
$2.9448
$9.70
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Nome
Foghorn Therapeutics Inc
Settore
Industria
Telefono
617-586-3100
Indirizzo
500 TECHNOLOGY SQUARE, CAMBRIDGE
Confronta FHTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.41 | 243.64M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Ripresa | B. Riley Securities | Buy |
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Iniziato | B. Riley Securities | Buy |
| 2024-09-03 | Iniziato | Jefferies | Buy |
| 2024-08-19 | Iniziato | Evercore ISI | Outperform |
| 2023-03-28 | Iniziato | BofA Securities | Buy |
| 2023-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2021-11-22 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-17 | Iniziato | Cowen | Outperform |
| 2020-11-17 | Iniziato | Goldman | Buy |
| 2020-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-17 | Iniziato | Wedbush | Outperform |
Mostra tutto
Foghorn Therapeutics Inc Borsa (FHTX) Ultime notizie
Is Foghorn Therapeutics Inc. stock safe for conservative investors2025 Sector Review & Safe Capital Preservation Plans - newser.com
Is Foghorn Therapeutics Inc. stock bottoming outQuarterly Profit Review & Daily Price Action Insights - newser.com
Published on: 2025-11-02 14:15:30 - newser.com
Will Foghorn Therapeutics Inc. continue its uptrend2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Published on: 2025-11-02 02:35:38 - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.Market Performance Report & Verified Stock Trade Ideas - newser.com
Why Foghorn Therapeutics Inc. is moving todayPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-11-01 05:22:36 - newser.com
What does recent volatility data suggest for Foghorn Therapeutics Inc.Watch List & Free Verified High Yield Trade Plans - newser.com
Foghorn Therapeutics shares progress on three protein degrader programs - BioWorld MedTech
Can swing trading help recover from Foghorn Therapeutics Inc. lossesJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Foghorn Therapeutics Inc. stock could outperform in 2025Earnings Trend Report & Weekly High Return Forecasts - newser.com
Applying big data sentiment scoring on Foghorn Therapeutics Inc.Earnings Summary Report & Weekly Market Pulse Updates - newser.com
Has Foghorn Therapeutics Inc. formed a bullish divergencePortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
Foghorn Therapeutics advances ARID1B, CBP, EP300 development - Traders Union
Foghorn Therapeutics Announces Key Pipeline Updates - TipRanks
Foghorn Therapeutics Updates on Selective Degrader Programs and Virtual Investor Event Announcement - Quiver Quantitative
Foghorn Therapeutics Inc Announces Pipeline Updates for Degrader Programs - TradingView
Foghorn (Nasdaq: FHTX) updates degraders: ARID1B tied to 5% of solid tumors; CBP IND 2026 - Stock Titan
Momentum divergence signals in Foghorn Therapeutics Inc. chartQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - newser.com
How risky is Foghorn Therapeutics Inc. stock nowEarnings Growth Report & Consistent Profit Trading Strategies - newser.com
Volatility clustering patterns for Foghorn Therapeutics Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Foghorn Therapeutics Inc Azioni (FHTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):